Opinion/decision on a Paediatric investigation plan (PIP): Minjuvi, tafasitamab, decision type: W: decision granting a waiver in all age groups for all conditions or indications, therapeutic area: Neoplasms benign, malignant and unspecified (incl cysts an

Opinion/decision on a Paediatric investigation plan (PIP): Minjuvi, tafasitamab, decision type: W: decision granting a waiver in all age groups for all conditions or indications, therapeutic area: Neoplasms benign, malignant and unspecified (incl cysts and polyps), PIP number: P/0344/2024